← Back to guidelines
Cardiology42 papers

Intramural esophageal hematoma

Last edited: 4/15/2026

Overview

Intramural esophageal hematoma (IEMH) is a rare but serious condition characterized by bleeding within the esophageal wall, often presenting with chest pain, dysphagia, and potentially hemodynamic instability. 1

Diagnosis

  • Clinical Presentation: Chest pain, dysphagia, and dyspnea.
  • Imaging: Transthoracic echocardiography (TTE) and CT angiography are crucial for diagnosis, showing aortic involvement in cases related to aortic intramural hematoma (IMH).
  • Grading: Not specifically detailed in provided abstracts; typically involves assessment of hematoma size and aortic diameter.
  • Management

  • First-Line Treatments:
  • - Optimal Medical Therapy: Includes blood pressure control, pain management, and close monitoring. - Emergency Surgery: Indicated for unstable patients or those meeting specific size criteria (ascending aorta ≥45 mm, IMH thickness ≥8 mm).
  • Adjunctive Treatments:
  • - Repetitive Imaging: To monitor hematoma resolution and aortic changes. - Conservative Management: Suitable for stable patients with careful observation and medical support 12.

    Special Populations

  • Elderly and Comorbidities: Conservative management may be preferred in high-risk patients due to comorbidities, as seen in a case where surgery was deferred due to patient instability and comorbidities 1.
  • Key Recommendations

  • Stable patients with acute type A aortic IMH may be managed conservatively with optimal medical therapy and close monitoring, though this approach is associated with higher late mortality compared to surgical intervention (Evidence: Moderate) 2.
  • Emergency surgery should be considered for patients with hemodynamic instability or specific anatomical criteria (ascending aorta ≥45 mm, IMH thickness ≥8 mm) to reduce mortality risk (Evidence: Moderate) 2.
  • Repetitive imaging is essential for monitoring the progression and resolution of IMH in conservatively managed patients (Evidence: Weak) 1.
  • References

    1 Illum E, Nielsen LH, Mortensen SB, Schneider IR. Long-term survival and rehabilitation of an inoperable patient with extensive type A aortic intramural haematoma, haemopericardium and haemomediastinum. BMJ case reports 2025. link 2 Yang J, Yu C, Li X, Kuang J, Chen Z, Xiao F et al.. Therapeutic management of acute type A aortic intramural hematoma. BMC cardiovascular disorders 2021. link

    Original source

    1. [1]
    2. [2]
      Therapeutic management of acute type A aortic intramural hematoma.Yang J, Yu C, Li X, Kuang J, Chen Z, Xiao F et al. BMC cardiovascular disorders (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG